BackUltragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Target Price

Analysts' 12-month price predictions for RARE.

Share Price

$45.11

Average Target Price

$109.43142.6% upside

7 analysts in the last 4 months

High: $135 | Low: $67

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-06-06Goldman SachsSalveen Richter$6748.5% upsideOpen
2024-05-31Stifel NicolausDae Gon Ha$127181.5% upsideOpen
2024-05-31Raymond JamesChristopher Raymond$135199.3% upsideOpen
2024-05-31Robert W. BairdJoel Beatty$7259.6% upsideOpen
2024-05-31Canaccord GenuityWhitney Ijem$111146.1% upsideOpen
2024-04-15Stifel NicolausDae Gon Ha$124174.9% upsideOpen
2024-04-15Raymond JamesChristopher Raymond$130188.2% upsideOpen
2023-02-03Morgan Stanley$95110.6% upsideOpen
2022-12-30H.C. Wainwright$8281.8% upsideOpen
2022-07-28Piper SandlerChristopher Raymond$130188.2% upsideOpen
2022-07-01Stifel Nicolaus$142214.8% upsideOpen
2022-05-24Goldman Sachs$101123.9% upsideOpen
2022-05-18Piper SandlerChristopher Raymond$135199.3% upsideOpen
2022-05-06Morgan Stanley$109141.6% upsideOpen
2022-05-06Leerink Partners$115154.9% upsideOpen
2022-01-10Cowen & Co.Yaron Werber$124174.9% upsideOpen
2021-11-03CitigroupYigal Nochomovitz$150232.5% upsideOpen
2021-11-03WedbushLaura Chico$92103.9% upsideOpen
2021-09-27Piper SandlerChristopher Raymond$170276.9% upsideOpen
2021-08-19UBSEsther Rajavelu$7361.8% upsideOpen
2021-08-03BarclaysGena Wang$141212.6% upsideOpen